Ovarian cancer has seen a significant shift in its treatment paradigm with the introduction of poly (ADP-ribose) polymerase (PARP) inhibitors, which are now standard in the maintenance setting ...

A research team at the Medical University of Vienna led by Maria Sibilia has investigated a new combination therapy against cancer. This therapy employs systemic administration of the tissue hormone ...

and a therapist who feels a strong alliance with their client is more likely to understand their challenges and help create a treatment plan that works for that individual. The therapeutic ...

As a result, therapy is considered the first-line treatment. But what is perhaps more important, unlike with medication, where the therapeutic effects stop when treatment ends, the effectiveness ...